These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31742901)

  • 21. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Steinacker P; Hendrich C; Sperfeld AD; Jesse S; von Arnim CA; Lehnert S; Pabst A; Uttner I; Tumani H; Lee VM; Trojanowski JQ; Kretzschmar HA; Ludolph A; Neumann M; Otto M
    Arch Neurol; 2008 Nov; 65(11):1481-7. PubMed ID: 19001167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.
    Kmezic I; Samuelsson K; Finn A; Upate Z; Blennow K; Zetterberg H; Press R
    Eur J Neurol; 2022 Sep; 29(9):2810-2822. PubMed ID: 35638376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes.
    Pijnenburg YA; Verwey NA; van der Flier WM; Scheltens P; Teunissen CE
    Alzheimers Dement (Amst); 2015 Dec; 1(4):505-12. PubMed ID: 27239528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
    Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum.
    Illán-Gala I; Alcolea D; Montal V; Dols-Icardo O; Muñoz L; de Luna N; Turón-Sans J; Cortés-Vicente E; Sánchez-Saudinós MB; Subirana A; Sala I; Blesa R; Clarimón J; Fortea J; Rojas-García R; Lleó A
    Neurology; 2018 Oct; 91(17):e1619-e1628. PubMed ID: 30291183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.
    Behzadi A; Pujol-Calderón F; Tjust AE; Wuolikainen A; Höglund K; Forsberg K; Portelius E; Blennow K; Zetterberg H; Andersen PM
    Sci Rep; 2021 Nov; 11(1):22128. PubMed ID: 34764380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study.
    Li JY; Dai Y; Sun XH; Ren HT; Shen DC; Yang XZ; Liu MS; Cui LY
    Brain Behav; 2023 May; 13(5):e2997. PubMed ID: 37070132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis.
    Falzone YM; Domi T; Mandelli A; Pozzi L; Schito P; Russo T; Barbieri A; Fazio R; Volontè MA; Magnani G; Del Carro U; Carrera P; Malaspina A; Agosta F; Quattrini A; Furlan R; Filippi M; Riva N
    Eur J Neurol; 2022 Jul; 29(7):1930-1939. PubMed ID: 35263489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Majumder V; Gregory JM; Barria MA; Green A; Pal S
    BMC Neurol; 2018 Jun; 18(1):90. PubMed ID: 29954341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
    Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
    J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High levels of neurofilament light and YKL-40 in cerebrospinal fluid are related to poor outcome in ALS.
    Rosén C; Mitre B; Nellgård B; Axelsson M; Constantinescu R; Andersen PM; Dalla K; Blennow K; Nilsson G; Zetterberg H; Rosén H
    J Neurol Sci; 2024 Aug; 463():123112. PubMed ID: 38972199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease.
    Abu-Rumeileh S; Baiardi S; Ladogana A; Zenesini C; Bartoletti-Stella A; Poleggi A; Mammana A; Polischi B; Pocchiari M; Capellari S; Parchi P
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1181-1188. PubMed ID: 32928934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis.
    Tortelli R; Copetti M; Ruggieri M; Cortese R; Capozzo R; Leo A; D'Errico E; Mastrapasqua M; Zoccolella S; Pellegrini F; Simone IL; Logroscino G
    Eur J Neurol; 2015 Jan; 22(1):215-8. PubMed ID: 24750431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: A longitudinal follow-up study.
    Chen PC; Wu D; Hu CJ; Chen HY; Hsieh YC; Huang CC
    J Neurol Sci; 2020 Nov; 418():117070. PubMed ID: 32836016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF neurofilament protein analysis in the differential diagnosis of ALS.
    Reijn TS; Abdo WF; Schelhaas HJ; Verbeek MM
    J Neurol; 2009 Apr; 256(4):615-9. PubMed ID: 19296046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.
    Gaiottino J; Norgren N; Dobson R; Topping J; Nissim A; Malaspina A; Bestwick JP; Monsch AU; Regeniter A; Lindberg RL; Kappos L; Leppert D; Petzold A; Giovannoni G; Kuhle J
    PLoS One; 2013; 8(9):e75091. PubMed ID: 24073237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis.
    Li S; Ren Y; Zhu W; Yang F; Zhang X; Huang X
    J Neurol Sci; 2016 Aug; 367():269-74. PubMed ID: 27423602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.